Sleep disorders afflict vast populations globally, manifesting in diverse forms such as chronic insomnia, obstructive sleep apnea, and circadian rhythm disruptions. These conditions exact a profound toll on physiological health, cognitive capacity, and emotional resilience. Historically, sleep research has prioritized central nervous system mechanisms; however, this landmark review underscores the critical influence of peripheral systems, particularly gut microbiota, in modulating brain function and behavior. The convergence of microbiome science with sleep physiology heralds a transformative era whereby digestive ecosystems are recognized as active contributors to sleep regulation rather than passive participants.

The gut microbiome—comprising an immense and dynamic population of bacteria, viruses, and fungi—engages in continuous bidirectional communication with the brain via neural, immune, and endocrine routes. Central among these is the vagus nerve, which enables rapid neuronal crosstalk, while circulating immune factors and microbial metabolites serve as systemic messengers capable of traversing the blood-brain barrier. Professor Lu emphasizes that aberrations in microbial community structure, or dysbiosis, consistently correlate with sleep disruptions, suggesting that altered gut ecology is both a marker and a mediator of sleep pathology.

Human clinical investigations alongside controlled animal studies reveal compelling patterns: individuals suffering from chronic insomnia exhibit markedly reduced microbial diversity and deficits in bacterial families known for beneficial metabolic functions. Similarly, patients diagnosed with obstructive sleep apnea display diminished alpha-diversity, with microbial signatures correlating directly with disease severity measures such as apnea-hypopnea indices and oxygen saturation. These findings not only establish a robust associative framework but also hint at mechanistic underpinnings.

At the molecular interface of gut-brain communication, microbial metabolites emerge as critical modulators. Short-chain fatty acids (SCFAs), particularly butyrate, synthesized by bacterial fermentation of dietary fibers, demonstrate neuroprotective and anti-inflammatory properties that preserve sleep integrity. Empirical data from clinical trials suggest that butyrate supplementation enhances sleep quality in inflammatory bowel disease patients, while animal experiments confirm its capacity to attenuate inflammation and cognitive deficits induced by sleep deprivation. Altered bile acid profiles further delineate gut microbiome involvement, with chronic insomnia linked to elevated primary bile acids and depleted secondary bile acids, implicating a dysregulated microbiota-bile acid axis that may exacerbate cardiometabolic comorbidities associated with poor sleep.

The production of neurotransmitters by gut microbes elucidates additional pathways of influence. Select strains of Lactobacillus and Bifidobacterium harbor genes responsible for generating gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter central to sleep initiation and maintenance. Electroencephalographic evidence corroborates that both endogenous and exogenous GABA can modulate cortical activity, reinforcing the gut’s neurochemical impact. Moreover, the gut is the predominant extraneural site of serotonin synthesis, with more than 90% of the body’s serotonin produced within the intestinal tract. Serotonin’s rhythmic fluctuations align with sleep-wake cycles, and disturbances in its metabolism—linked to gut microbiota alterations—may precipitate circadian misalignment and sleep deficits. The gastrointestinal tract also paradoxically serves as a major melatonin reservoir, with concentrations vastly exceeding plasma levels, further emphasizing the gut’s centrality in circadian biology.

Delineating the microbial landscapes characteristic of specific sleep disorders, the review synthesizes extensive data sets revealing both unique and overlapping microbial taxonomic shifts. Chronic insomnia studies involving thousands have documented consistent declines in Ruminococcaceae species, bacterial groups implicated in bile acid metabolism and systemic inflammation. Obstructive sleep apnea research echoes this narrative, where diminished levels of these commensals associate with hypoxia-induced gut inflammation. Investigations into circadian disruption conditions, especially in shift workers, reveal compositional microbiota oscillations tied to altered metabolic pathways that favor glucose intolerance, signifying a link between microbiota and metabolic sequelae of sleep loss. Likewise, rarer disorders such as narcolepsy and REM sleep behavior disorder exhibit discrete microbial signatures, some predictive of neurodegenerative progression, offering novel biomarker avenues.

Sleep disturbances frequently co-occur with neuropsychiatric disorders, including major depressive disorder, anxiety, autism spectrum disorder, and Parkinson’s disease. The review highlights commensurate shifts in gut microbial genera like Blautia, Coprococcus, and Dorea correlating with sleep parameters in depression, as well as decreased Faecalibacterium and Agathobacter in autistic children with sleep impairments. Parkinson’s disease subtypes characterized by early sleep disturbances similarly demonstrate gut dysbiosis, marked by elevated Escherichia coli and Akkermansia muciniphila alongside diminished SCFA producers, underscoring shared pathogenic routes.

Translating mechanistic elucidations into therapeutic potentials, the review appraises emerging microbiota-targeted interventions. Probiotic administration manifests tangible improvements in sleep metrics across chronic insomnia, Parkinson’s disease, and substance use disorders, with strains such as Lactobacillus plantarum PS128 and Bifidobacterium breve CCFM1025 demonstrating modulation of neurophysiological markers including delta power during deep sleep and attenuation of hypothalamic-pituitary-adrenal axis hyperactivity. Complementary animal research substantiates these findings, noting enhancements in non-rapid eye movement sleep duration and reductions in anxiety-like behaviors consequent to probiotic supplementation.

Prebiotics—nondigestible fibers fostering beneficial microbial growth—also show promise in ameliorating sleep disruptions, particularly those induced by circadian misalignment and metabolic disorders. Clinical trials affirm that compounds like partially hydrolyzed guar gum and resistant dextrin improve sleep quality scores, while animal studies suggest mechanisms involving bile acid metabolism and gut barrier integrity. Synbiotics, combining both probiotics and prebiotics, offer synergistic effects, exhibiting notable efficacy in post-acute COVID-19 syndrome and other sleep-compromised populations, enhancing subjective sleep quality and physiological markers in randomized controlled settings.

Fecal microbiota transplantation (FMT) represents a potent, albeit complex, therapeutic frontier. Clinical interventions deploying FMT in chronic insomnia patients with comorbidities have yielded remarkable augmentations in sleep quality and symptom alleviation, accompanied by favorable shifts in gut bacterial populations. Similar benefits extend to fibromyalgia and pediatric autism sufferers, signaling FMT’s expansive potential. Nonetheless, practical constraints—stringent donor screening, procedural standardization, regulatory hurdles—currently restrict widespread FMT application to research contexts and select refractory cases.

This comprehensive synthesis proposes an integrated research framework designed to propel the field forward. The authors advocate a tiered approach beginning with multimodal phenotyping, incorporating neuroimaging modalities alongside robust microbiome and metabolomic profiling. Subsequent tiers focus on biomarker discovery through machine learning-driven multi-omic integration, causal inference employing germ-free animal models and longitudinal human trials, and the rigorous evaluation of microbiota-directed interventions through carefully controlled clinical studies. Harmonization of methodologies and standardization of biomarkers are emphasized as critical to advancing translatability and reproducibility.

Despite promising advancements, the review acknowledges persistent challenges, including interindividual variability in microbiota compositions and responses to interventions, methodological discrepancies across studies, and incomplete long-term safety data for microbiome-targeted therapies. Prioritizing well-powered, standardized clinical trials—particularly targeting conditions with robust microbiome-sleep mechanistic links like chronic insomnia and obstructive sleep apnea—will be imperative. Additionally, elucidating personalized microbial signatures and tailoring interventions accordingly offers an exciting horizon in precision medicine for sleep disorders.

In conclusion, this landmark review firmly establishes the microbiota-gut-brain axis as a central regulator in the complex architecture of sleep physiology and pathology. The identification of shared microbial alterations across a spectrum of sleep disorders accentuates the gut microbiome’s dual roles as both consequence and catalyst of sleep dysfunction. By bridging gaps across disciplines, this work lays a robust foundation for microbiota-based diagnostics and therapeutics, with the potential to revolutionize management strategies for sleep disorders globally. As the nexus of microbiology, neuroscience, and clinical medicine strengthens, the vision of harnessing gut microbiota to restore healthy sleep and enhance brain function draws ever closer to reality.

Subject of Research: People
Article Title: Brain-gut-microbiota interactions in sleep disorders
News Publication Date: 4 November 2025
Web References: https://doi.org/10.61373/bm025i.0128
References: The review article published in Brain Medicine supported by STI2030-Major Projects and the National Natural Science Foundation of China
Image Credits: Lin Lu
Keywords: microbiota-gut-brain axis, sleep disorders, gut microbiome, chronic insomnia, obstructive sleep apnea, circadian rhythm, short-chain fatty acids, bile acids, neurotransmitters, probiotics, fecal microbiota transplantation, sleep regulation

The study is notable for its robust cross-sectional design, analyzing data from 14,492 participants, making it one of the most comprehensive investigations into these two correlated health issues. The researchers first employed weighted logistic regression to establish a statistically significant association between depression and OSA, with depression increasing the odds of developing OSA by 31%. This finding persisted across multiple models, underscoring a consistent positive relationship that adds critical epidemiological evidence to a previously equivocal field.

Beyond determining the association, the research team sought to explore the nuances of this relationship by conducting interaction effect analyses to see if any subpopulations exhibited differential risks. Intriguingly, no statistically significant interactions emerged across various demographic or health-related subgroups, suggesting that the depression-OSA link is broadly applicable across diverse segments of the population. This has vast implications for public health strategies, emphasizing the universal importance of screening for sleep apnea in patients presenting with depressive symptoms.

One of the most innovative aspects of the study was the integration of machine learning techniques to predict OSA risk specifically among individuals with depression. Employing a range of algorithms, including neural networks, random forests, and gradient boosting, the authors identified the neural network as the most effective model. It achieved superior performance metrics, including the highest Youden’s Index, area under the curve (AUC), and Cohen’s Kappa scores, thereby demonstrating impressive predictive reliability.

The power of this machine learning approach was further enhanced by the use of Shapley Additive Explanations (SHAP), an interpretability method that quantifies the contribution of each feature to the prediction. The SHAP analysis illuminated a multifaceted landscape of risk factors significantly associated with OSA in depressed individuals. Among the most crucial predictors were body mass index (BMI), age, marital status, hypertension, caffeine intake, sex, alcohol consumption, and fat intake. This multifactorial insight elucidates the complex biopsychosocial dimensions underlying OSA risk, going beyond simplistic clinical models.

Importantly, the identification of lifestyle variables such as caffeine and fat intake as influential predictors introduces novel avenues for therapeutic intervention and patient education. These findings highlight the potential for personalized lifestyle modifications to mitigate OSA risk among those battling depression, suggesting a holistic approach to healthcare that integrates diet, mental health, and sleep medicine.

Moreover, the clear link between hypertension and OSA among depressed patients reinforces the critical need for integrated cardiovascular assessment in this population. Since OSA has well-documented cardiovascular implications, early identification and management become pivotal in reducing the burden of secondary complications, thereby improving overall prognosis.

This research also stresses the significance of demographic details like age and marital status, often overlooked in clinical evaluations. Understanding these social determinants can enhance screening strategies, making them more socially sensitive and contextually appropriate, which is essential for improving healthcare equity and outcomes.

The implications of this study extend to clinical practice by advocating for routine assessment of depressive symptoms in patients diagnosed with OSA and vice versa. Such bidirectional screening could facilitate early detection, timely intervention, and personalized management plans that address both mental and sleep health concurrently, potentially breaking the cycle that exacerbates these co-morbid conditions.

Furthermore, the study sets a precedent for the application of advanced data-driven technologies in psychiatric and sleep research. The successful integration of machine learning with epidemiological data underscores the transformative potential of computational methods to enhance predictive accuracy and clinical decision-making.

The authors conclude by emphasizing the urgent need for healthcare providers to recognize depression as a significant risk factor for OSA, advocating for an interdisciplinary approach that integrates psychiatry, pulmonology, and lifestyle medicine. Their findings warn that neglecting depressive symptoms can delay OSA diagnosis, worsening patient outcomes and increasing healthcare costs.

In sum, this study represents a milestone in understanding the intricate relationship between depression and obstructive sleep apnea. By augmenting traditional epidemiological methods with machine learning and interpretability frameworks, it provides a comprehensive, data-rich foundation for future research and clinical interventions aimed at mitigating the intertwined burdens of mental health disorders and sleep apnea on public health.

Subject of Research: The association between depression and obstructive sleep apnea (OSA), and prediction of OSA risk factors in individuals with depression using machine learning techniques.

Article Title: Investigating the role of depression in obstructive sleep apnea and predicting risk factors for OSA in depressed patients: machine learning-assisted evidence from NHANES

Article References: Cheng, X., Liu, F., Zhang, X. et al. Investigating the role of depression in obstructive sleep apnea and predicting risk factors for OSA in depressed patients: machine learning-assisted evidence from NHANES. BMC Psychiatry 25, 964 (2025). https://doi.org/10.1186/s12888-025-07414-x

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-07414-x

Obstructive sleep apnea, a condition characterized by repeated airway blockage during sleep, leads to intermittent hypoxia — periods where blood oxygen levels drop significantly. These fluctuations disrupt the sleep architecture, causing fragmented sleep and reduced oxygen saturation that can persist throughout the night. Although OSA primarily affects the respiratory system, its consequences extend far beyond, impacting the delicate vascular network of the brain.

Researchers from the University of California Irvine, led by neuroscientist Bryce A. Mander, PhD, conducted a detailed investigation into how oxygen desaturation during sleep stages correlates with damage in brain structures critical for memory processing. Their focus on REM sleep was especially significant given the role this phase plays in consolidating memory and managing emotional information. By employing advanced neuroimaging techniques, the study explored the microvascular changes that underlie brain tissue damage and their functional repercussions.

The investigation included 37 cognitively normal participants with an average age of 73, none of whom were under the influence of sleep medications, ensuring that the findings captured natural sleep physiology. Among these volunteers, 24 were diagnosed with obstructive sleep apnea. Throughout the night, participants underwent polysomnography, a comprehensive sleep study measuring sleep stages, breathing interruptions, and real-time oxygen saturation levels.

In parallel, participants underwent magnetic resonance imaging (MRI) scans designed to quantify white matter hyperintensities – bright regions visible on MRI which are indicative of small vessel disease and white matter injury. These lesions often result from chronic hypoxia or ischemia, and their presence has been linked to cognitive impairment and dementia. Investigators noted a robust relationship between the severity of oxygen drops during REM sleep and the volume of white matter damage.

Delving deeper into memory-related brain structures, the research team evaluated the hippocampus and entorhinal cortex, two areas known to be pivotal in memory formation and retrieval. The results were striking: increased white matter hyperintensities correlated strongly with shrinkage of the hippocampus and thinning of the entorhinal cortex. These morphological changes provide a biological basis for the subtle memory deficits observed in aging individuals with OSA.

Cognitive testing conducted before and after sleep revealed that impairments in memory consolidation—i.e., the brain’s ability to solidify new experiences overnight—were linked to entorhinal cortex thinning. This finding points to a direct pathway through which oxygen deprivation can interrupt neuronal circuits and degrade sleep-dependent memory processes.

Importantly, the study emphasizes that a drop in blood oxygen saturation below the threshold of 90% during sleep is a critical risk factor for small vessel brain damage. Both the minimum oxygen saturation levels and the total duration spent below this cutoff were powerful predictors of white matter injury extent. This underscores the urgency of diagnosing and managing OSA to prevent long-term cerebrovascular damage.

While the study establishes a strong associative link, the researchers clarify that causality cannot yet be confirmed. Multiple intertwined factors such as age-related vascular changes, genetics, and lifestyle may also contribute to the observed brain atrophy and cognitive decline. Nevertheless, this evidence advances the understanding of OSA’s role in neurodegeneration and provides a biological target for future interventions.

The implications of these findings are vast and far-reaching. Given that obstructive sleep apnea is prevalent, especially in older populations, and is often undiagnosed, recognizing its potential impact on brain health could transform clinical approaches to both sleep and neurodegenerative disorders. Early screening and effective treatment of sleep apnea may constitute a vital preventive strategy against cognitive deterioration.

Notably, the study sample was primarily composed of white and Asian individuals, and the authors caution that results may not generalize to all ethnic groups equally. Future research should expand demographic representation and explore the influence of racial and environmental factors in the relationship between OSA and brain health.

This research was supported by the National Institute on Aging and the American Academy of Sleep Medicine Foundation, highlighting the collaborative effort between sleep medicine and neuroscience communities. Their work paves the path for integrated approaches emphasizing brain oxygenation and vascular health as pillars of preventing age-related memory disorders.

As the scientific community continues to unravel the complexities of sleep’s role in brain function, the findings from this study underscore the silent but significant threat posed by untreated obstructive sleep apnea. Through greater awareness and medical innovation, preserving brain structure and function during aging may become a feasible reality.

Subject of Research: Obstructive sleep apnea and its association with brain microvascular damage and memory-related brain region degeneration.

Article Title: Oxygen Desaturation During REM Sleep in Obstructive Sleep Apnea Linked to Brain Degeneration and Memory Impairment

News Publication Date: May 7, 2025

Web References:

• Neurology Journal
• American Academy of Neurology
• BrainandLife.org

Keywords: Obstructive sleep apnea, REM sleep, oxygen saturation, white matter hyperintensities, hippocampus, entorhinal cortex, memory consolidation, brain degeneration, cognitive decline, small vessel disease, aging, sleep disorders

Obstructive sleep apnea affects millions worldwide, significantly impairing sleep quality and increasing the risk of severe health events such as heart attacks and strokes. Despite widespread awareness, non-invasive interventions to ameliorate the neurological impact of OSA remain limited. This pioneering research leverages the intricate relationship between auditory stimuli and brain function, focusing on how classical Indian ragas—specifically Neelambari and Kapi—modulate cortical connectivity patterns in OSA patients.

The study involved collecting electroencephalogram (EEG) data from twelve subjects diagnosed with OSA, under three distinct conditions: listening to the raga Neelambari, listening to Kapi, and a control condition with no music. EEG, a non-invasive technique capturing electrical activity produced by brain neurons, provided detailed insights into regional brain dynamics influenced by these musical interventions. The researchers meticulously pre-processed EEG signals using bandpass and notch filters to eliminate noise and artifacts, ensuring high-fidelity data for analysis.

To dissect the EEG signals, the team employed wavelet packet decomposition (WPD), an advanced time-frequency domain method that isolates EEG sub-bands critical for understanding brain connectivity. These sub-bands—delta, theta, alpha, and beta—are associated with different cognitive and physiological functions. By focusing on these distinct frequencies, the researchers could assess how musical exposure modulates functional interactions within the brain’s networks.

Brain connectivity was analyzed using Pearson correlation coefficients calculated from the absolute values of WPD detail coefficients. This quantitative approach enabled the team to construct connectivity matrices representing the strength of synchronization between various brain regions. Further application of graph theory metrics, particularly node strength, allowed for a nuanced interpretation of frequency-specific neural communication patterns.

Remarkably, the data revealed significantly increased connectivity in the right hemisphere’s frontal and temporal regions—specifically electrodes F8, FC6, and T8—during exposure to Neelambari music. The beta frequency band, often linked with active concentration and cognitive engagement, exhibited correlation values ranging from 0.943 to 0.998. Similarly, the delta band, associated with deep sleep and restorative processes, showed robust correlations between 0.945 and 0.999, indicating profound neural synchronization.

In comparison, the alpha and theta bands, typically connected to relaxation and drowsiness, displayed moderate but meaningful correlations during Neelambari listening sessions, ranging from 0.746 to 0.996. This suggests that Neelambari not only stimulates higher-order cognitive processing but also promotes states conducive to restful neural recovery—both critical in addressing OSA’s detrimental effects.

Contrastingly, Kapi music elicited lower overall correlation values across all EEG bands, denoting less pronounced neural synchronization. The higher correlation indices during Neelambari underscore its superior potential to enhance brain connectivity and potentially counterbalance the cognitive deficits associated with sleep apnea. These findings open avenues for integrating specific music therapies into clinical management plans for OSA patients.

The implications of this research extend beyond sleep disorders, suggesting music’s ability to modulate brain networks dynamically could have far-reaching applications in neurorehabilitation and cognitive enhancement. By boosting connectivity in key regions responsible for attention, memory, and emotional regulation, music listening may serve as a low-cost, non-invasive adjunct treatment to improve quality of life among patients struggling with various neurological conditions.

Importantly, the study’s use of objective, quantitative metrics marks a significant advancement in the evaluation of music-based interventions. The combination of WPD and graph theory offers a powerful framework to decode complex brain activities, moving the field closer to personalized, evidence-based applications of auditory stimuli for neurological health.

While promising, the research is based on a relatively small sample size, warranting further studies involving larger, more diverse populations to validate and generalize the findings. Future work could also explore long-term effects of sustained music therapy and potential synergies with conventional OSA treatments such as continuous positive airway pressure (CPAP).

This innovative investigation by Rajeswari, Navaneethan, Sreedhar, and colleagues exemplifies the growing intersection of neuroscience, bioengineering, and musicology. Their work not only illuminates the hidden power of sound to rewire dysfunctional brain networks but also inspires a fresh perspective on combating widespread sleep disorders through the universal language of music.

As the global burden of sleep apnea continues to rise, these insights provide a beacon of hope, suggesting that therapeutic sounds might one day form an integral part of multidisciplinary approaches to restore healthy brain function. The neurophysiological evidence supporting Neelambari’s efficacy invites both clinicians and researchers to rethink traditional paradigms and embrace the harmonizing potential of music in medicine.

Subject of Research: Impact of music interventions on brain connectivity in obstructive sleep apnea patients

Article Title: Music interventions and obstructive sleep apnea: a brain connectivity analysis

Article References:
Rajeswari, J., Navaneethan, S., Sreedhar, P.S.S. et al. Music interventions and obstructive sleep apnea: a brain connectivity analysis. BioMed Eng OnLine 24, 45 (2025). https://doi.org/10.1186/s12938-025-01382-9

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12938-025-01382-9